Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BEAUTIP-D
- Development stage
- Unknown
- Lead developer
- Laboratorio Arama
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Administration
- Oral
01
Overview
BEAUTIP-D is a nutritional supplement powder developed by Laboratorio Arama, a subsidiary of OPKO Health, designed to support bone and joint health. The formulation contains a combination of 3000 mg bovine Type I hydrolyzed collagen, 1000 mg calcium, 800 IU vitamin D, and 400 mg magnesium per serving. It is primarily indicated for addressing calcium deficiencies in bones and teeth, while also supporting muscle function and skin health. The product is marketed in Chile and other Latin American regions as a sugar-free, blueberry-flavored powder packaged in individual sachets for daily oral administration.
- Brand names
- BEAUTIP-D
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on BEAUTIP-D.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BEAUTIP-D.